This invention relates to novel naphthyl substituted azabicyclo
derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In
other aspects the invention relates to the use of these compounds in a
method for therapy and to pharmaceutical compositions comprising the
compounds of the invention.